NEW YORK – Researchers at the Colorado Center for Personalized Medicine’s (CCPM) Biobank are collecting patient samples in order to analyze genetic data using SNP microarrays to provide pharmacogenetic (PGx) results.
NEW YORK – Researchers at the Colorado Center for Personalized Medicine’s (CCPM) Biobank are collecting patient samples in order to analyze genetic data using SNP microarrays to provide pharmacogenetic (PGx) results.